AMBIPAR EMERGENCY RESPONSE (AMBI) Stock Fundamental Analysis

NYSEARCA:AMBI • KYG025321020

0.5396 USD
-0.06 (-10.31%)
Last: Oct 28, 2025, 08:04 PM
Fundamental Rating

3

AMBI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 80 industry peers in the Commercial Services & Supplies industry. AMBI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AMBI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • AMBI had negative earnings in the past year.
  • In the past year AMBI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AMBI reported negative net income in multiple years.
  • Of the past 5 years AMBI 4 years had a positive operating cash flow.
AMBI Yearly Net Income VS EBIT VS OCF VS FCFAMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

  • AMBI has a Return On Assets (-0.35%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of -1.42%, AMBI is in line with its industry, outperforming 43.37% of the companies in the same industry.
  • AMBI's Return On Invested Capital of 7.64% is fine compared to the rest of the industry. AMBI outperforms 71.08% of its industry peers.
  • AMBI had an Average Return On Invested Capital over the past 3 years of 8.34%. This is below the industry average of 10.66%.
Industry RankSector Rank
ROA -0.35%
ROE -1.42%
ROIC 7.64%
ROA(3y)0.97%
ROA(5y)1.73%
ROE(3y)12.32%
ROE(5y)14.66%
ROIC(3y)8.34%
ROIC(5y)N/A
AMBI Yearly ROA, ROE, ROICAMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

  • Looking at the Operating Margin, with a value of 14.95%, AMBI belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AMBI has declined.
  • With a Gross Margin value of 14.74%, AMBI is not doing good in the industry: 81.93% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of AMBI has declined.
Industry RankSector Rank
OM 14.95%
PM (TTM) N/A
GM 14.74%
OM growth 3Y-11.61%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.87%
GM growth 5YN/A
AMBI Yearly Profit, Operating, Gross MarginsAMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMBI is still creating some value.
  • The number of shares outstanding for AMBI remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, AMBI has a worse debt to assets ratio.
AMBI Yearly Shares OutstandingAMBI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMBI Yearly Total Debt VS Total AssetsAMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • AMBI has an Altman-Z score of 1.00. This is a bad value and indicates that AMBI is not financially healthy and even has some risk of bankruptcy.
  • AMBI has a worse Altman-Z score (1.00) than 66.27% of its industry peers.
  • The Debt to FCF ratio of AMBI is 10.73, which is on the high side as it means it would take AMBI, 10.73 years of fcf income to pay off all of its debts.
  • AMBI's Debt to FCF ratio of 10.73 is in line compared to the rest of the industry. AMBI outperforms 56.63% of its industry peers.
  • A Debt/Equity ratio of 2.00 is on the high side and indicates that AMBI has dependencies on debt financing.
  • The Debt to Equity ratio of AMBI (2.00) is worse than 79.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 10.73
Altman-Z 1
ROIC/WACC1.58
WACC4.83%
AMBI Yearly LT Debt VS Equity VS FCFAMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 1.79 indicates that AMBI should not have too much problems paying its short term obligations.
  • AMBI's Current ratio of 1.79 is fine compared to the rest of the industry. AMBI outperforms 66.27% of its industry peers.
  • AMBI has a Quick Ratio of 1.74. This is a normal value and indicates that AMBI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.74, AMBI is doing good in the industry, outperforming 74.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.74
AMBI Yearly Current Assets VS Current LiabilitesAMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

  • AMBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.09%, which is quite impressive.
  • The Revenue has grown by 25.42% in the past year. This is a very strong growth!
  • The Revenue has been growing by 58.09% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)67.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.99%
Revenue 1Y (TTM)25.42%
Revenue growth 3Y58.09%
Revenue growth 5YN/A
Sales Q2Q%10.36%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMBI Yearly Revenue VS EstimatesAMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1B 2B 3B

2

4. Valuation

4.1 Price/Earnings Ratio

  • AMBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMBI Price Earnings VS Forward Price EarningsAMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • AMBI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMBI is cheaper than 96.39% of the companies in the same industry.
  • AMBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMBI is cheaper than 98.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.56
EV/EBITDA 3.31
AMBI Per share dataAMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for AMBI!.
Industry RankSector Rank
Dividend Yield N/A

AMBIPAR EMERGENCY RESPONSE

NYSEARCA:AMBI (10/28/2025, 8:04:02 PM)

0.5396

-0.06 (-10.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners6.53%
Inst Owner Change2.1%
Ins Owners1.68%
Ins Owner ChangeN/A
Market Cap29.91M
Revenue(TTM)3.25B
Net Income(TTM)-20.56M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 0.56
P/OCF 0.38
P/B 0.11
P/tB N/A
EV/EBITDA 3.31
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.96
FCFY178.67%
OCF(TTM)1.42
OCFY262.66%
SpS10.93
BVpS4.88
TBVpS-2.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -1.42%
ROCE 10.07%
ROIC 7.64%
ROICexc 8.23%
ROICexgc 15.86%
OM 14.95%
PM (TTM) N/A
GM 14.74%
FCFM 8.82%
ROA(3y)0.97%
ROA(5y)1.73%
ROE(3y)12.32%
ROE(5y)14.66%
ROIC(3y)8.34%
ROIC(5y)N/A
ROICexc(3y)8.89%
ROICexc(5y)N/A
ROICexgc(3y)20.26%
ROICexgc(5y)N/A
ROCE(3y)10.88%
ROCE(5y)N/A
ROICexgc growth 3Y-14.73%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.49%
ROICexc growth 5YN/A
OM growth 3Y-11.61%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.87%
GM growth 5YN/A
F-Score3
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 10.73
Debt/EBITDA 3.58
Cap/Depr 41.78%
Cap/Sales 4.15%
Interest Coverage 3.35
Cash Conversion 52.13%
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.74
Altman-Z 1
F-Score3
WACC4.83%
ROIC/WACC1.58
Cap/Depr(3y)86.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.42%
Revenue growth 3Y58.09%
Revenue growth 5YN/A
Sales Q2Q%10.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.79%
EBIT growth 3Y39.74%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y277.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y436.92%
OCF growth 3Y87.11%
OCF growth 5YN/A

AMBIPAR EMERGENCY RESPONSE / AMBI FAQ

What is the ChartMill fundamental rating of AMBIPAR EMERGENCY RESPONSE (AMBI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AMBI.


Can you provide the valuation status for AMBIPAR EMERGENCY RESPONSE?

ChartMill assigns a valuation rating of 2 / 10 to AMBIPAR EMERGENCY RESPONSE (AMBI). This can be considered as Overvalued.


What is the profitability of AMBI stock?

AMBIPAR EMERGENCY RESPONSE (AMBI) has a profitability rating of 3 / 10.


How financially healthy is AMBIPAR EMERGENCY RESPONSE?

The financial health rating of AMBIPAR EMERGENCY RESPONSE (AMBI) is 3 / 10.